Robotic Modified Constraint -Induced Therapy in Patients With Spastic Hemiplegic Stroke Post Botulinum Toxin A Injection
Effects of Robotic Modified Constraint -Induced Therapy on Behavioral Outcomes and Motor-learning Process in Patients With Spastic Hemiplegic Stroke Post Botulinum Toxin Type A Injection: A Randomized Controlled Trial
Sponsor: Chang Gung Memorial Hospital
Listed as NCT03807557, this NA trial focuses on Hemiplegia, Spastic and Stroke and remains completed. Sponsored by Chang Gung Memorial Hospital, it has been updated 10 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
Status: Enrolling By Invitation → Completed
-
Apr 2021 — Sep 2021 [monthly]
Enrolling By Invitation NA
Status: Unknown Status → Enrolling By Invitation
▶ Show 5 earlier versions
-
Feb 2021 — Apr 2021 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Jan 2021 — Feb 2021 [monthly]
Enrolling By Invitation NA
-
Jul 2019 — Jan 2021 [monthly]
Enrolling By Invitation NA
-
Mar 2019 — Jul 2019 [monthly]
Enrolling By Invitation NA
-
Feb 2019 — Mar 2019 [monthly]
Enrolling By Invitation NA
First recorded
Jan 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chang Gung Memorial Hospital
- Chang Gung University
For direct contact, visit the study record on ClinicalTrials.gov .